Entity
  • IMAI MedTech

    Created in 2024
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    548
  • Activities

  • Technologies

  • Entity types

  • Location

    Wagistrasse, 8952 Schlieren, Switzerland

    Schlieren

    Switzerland

  • Employees

    Scale: 2-10

    Estimated: 13

  • Engaged corporates

    1
    0 1
  • Added in Motherbase

    3 months, 2 weeks ago
Description
  • Value proposition

    Adding the 3rd dimension to the detection of cancer

    IMAI is committed to improving cancer diagnostics by specializing in a rapid and automated tissue preparation approach, including digital tissue visualization of biopsies. IMAI strives to bring about a groundbreaking change in histology. The solution developed by IMAI avoids the time-consuming manual cutting of tissue into micrometer-thin slices. On the one hand, this enables complete quantification of the entire biopsy and, on the other hand, the digital 3D images support pathologists in their diagnosis with algorithms.

    Vision: To achieve 100% accuracy in cancer diagnostics.

    Mission: To drive a paradigm shift in cancer treatment outcomes through rapid and precise detection of cancer cells.

    MedTech, Tissue visualization, Cancer detection, Robotics, Protocol automation, and Digital pathology

  • Home | IMAI Medtech 3D Histology Zürich

    IMAI Medtech is on a mission to redefine the landscape of oncology diagnostics through its pioneering 3D histology technology. By focusing on the early and accurate diagnosis of cancer, IMAI aims to enhance therapeutic outcomes and significantly improve patient care.

  • https://www.imai-medtech.com/
Corporate interactions BETA
Corporate TypeTweets Articles
ETH Entrepreneur Club
ETH Entrepreneur Club
Startup accelerator & VC, Higher Education
ETH Entrepreneur Club
Startup accelerator & VC, Higher Education
Other

18 Oct 2024


Similar entities
Loading...
Loading...
Social network dynamics